Abstract:Abstract Background The breadth of the clinical spectrum underlying Pelizaeus-Merzbacher disease and spastic paraplegia type 2 is due to the extensive allelic heterogeneity in the X-linked PLP1 gene encoding myelin proteolipid protein (PLP). PLP1 mutations range from gene duplications of variable size found in 60-70% of patients to intragenic lesions present in 15-20% of patients. Methods Forty-eight male patients from 38 unrelated families with a PLP1-related disorder were studied. All DNA samples were screened for PLP1 gene duplications using real-time PCR. PLP1 gene sequencing analysis was performed on patients negative for the duplication. The mutational status of all 14 potential carrier mothers of the familial PLP1 gene mutation was determined as well as 15/24 potential carrier mothers of the PLP1 duplication. Results and Conclusions PLP1 gene duplications were identified in 24 of the unrelated patients whereas a variety of intragenic PLP1 mutations were found in the remaining 14 patients. Of the 14 different intragenic lesions, 11 were novel; these included one nonsense and 7 missense mutations, a 657-bp deletion, a microdeletion and a microduplication. The functional significance of the novel PLP1 missense mutations, all occurring at evolutionarily conserved residues, was analysed by the MutPred tool whereas their potential effect on splicing was ascertained using the Skippy algorithm and a neural network. Although MutPred predicted that all 7 novel missense mutations would be likely to be deleterious, in silico analysis indicated that four of them (p.Leu146Val, p.Leu159Pro, p.Thr230Ile, p.Ala247Asp) might cause exon skipping by altering exonic splicing elements. These predictions were then investigated in vitro for both p.Leu146Val and p.Thr230Ile by means of RNA or minigene studies and were subsequently confirmed in the case of p.Leu146Val. Peripheral neuropathy was noted in four patients harbouring intragenic mutations that altered RNA processing, but was absent from all PLP1 -duplication patients. Unprecedentedly, family studies revealed the de novo occurrence of the PLP1 duplication at a frequency of 20%.

Pelizaeus–Merzbacher disease: on the cusp of myelin medicine

Identification and Functional Study of Novel PLP1 Mutations in Chinese Patients with Pelizaeus–Merzbacher Disease

Novel Insight into the Potential Pathogenicity of Mitochondrial Dysfunction Resulting from PLP1 Duplication Mutations in Patients with Pelizaeus–Merzbacher Disease

Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing

The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients

MRI Findings of Pelizaeus-Merzbacher Disease Correlated with Phenotypes and Genetic Mutation

[Clinical and Genetic Analysis of a Family with Pelizaeus-Merzbacher Disease].

Proteolipid Protein 1 Gene Mutation in Nine Patients with Pelizaeus-Merzbacher Disease

Genotype–phenotype Correlation and Natural History Analyses in a Chinese Cohort with Pelizaeus–merzbacher Disease

Molecular Myelin Dysfunction in the Most Common Inherited Peripheral Neuropathies - CMT1A and HNPP

Generation of the Human Induced Pluripotent Stem Cell Line (Zjui005-A) from a Patient with Pelizaeus-Merzbacher Disease (PMD) Carrying a Novel Hemizygous Mutation in PLP1 Gene

Integrative Systems and Functional Analyses Reveal a Role of Dopaminergic Signaling in Myelin Pathogenesis.

Primary mitochondrial diseases: The intertwined pathophysiology of bioenergetic dysregulation, oxidative stress and neuroinflammation

Disrupting the transmembrane domain interface between PMP22 and MPZ causes peripheral neuropathy

Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases

Current and Emerging Clinical Treatment in Mitochondrial Disease

Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches

Study on proteolipid protein 1 gene mutation in a Chinese pedigree with Pelizaeus-Merzbacher disease

Primary mitochondrial diseases

Molecular Genetic Analysis of the PLP1 Gene in 38 Families with PLP1-related disorders: Identification and Functional Characterization of 11 Novel PLP1 Mutations

The Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies